126 related articles for article (PubMed ID: 12725709)
1. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.
Feinstein DL
Diabetes Technol Ther; 2003; 5(1):67-73. PubMed ID: 12725709
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.
Schmidt S; Moric E; Schmidt M; Sastre M; Feinstein DL; Heneka MT
J Leukoc Biol; 2004 Mar; 75(3):478-85. PubMed ID: 14657213
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents.
Kaundal RK; Sharma SS
Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853
[TBL] [Abstract][Full Text] [Related]
5. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.
Grommes C; Landreth GE; Heneka MT
Lancet Oncol; 2004 Jul; 5(7):419-29. PubMed ID: 15231248
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease.
Landreth GE; Heneka MT
Neurobiol Aging; 2001; 22(6):937-44. PubMed ID: 11755002
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease.
Landreth G
Curr Alzheimer Res; 2007 Apr; 4(2):159-64. PubMed ID: 17430241
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma as a therapeutic target in central nervous system diseases.
Sundararajan S; Jiang Q; Heneka M; Landreth G
Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
[TBL] [Abstract][Full Text] [Related]
10. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR
J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881
[TBL] [Abstract][Full Text] [Related]
11. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
12. A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis.
Guo Q; Sahoo SP; Wang PR; Milot DP; Ippolito MC; Wu MS; Baffic J; Biswas C; Hernandez M; Lam MH; Sharma N; Han W; Kelly LJ; MacNaul KL; Zhou G; Desai R; Heck JV; Doebber TW; Berger JP; Moller DE; Sparrow CP; Chao YS; Wright SD
Endocrinology; 2004 Apr; 145(4):1640-8. PubMed ID: 14701675
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
Sodhi RK; Singh N; Jaggi AS
Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):115-24. PubMed ID: 21607645
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
Tao L; Liu HR; Gao E; Teng ZP; Lopez BL; Christopher TA; Ma XL; Batinic-Haberle I; Willette RN; Ohlstein EH; Yue TL
Circulation; 2003 Dec; 108(22):2805-11. PubMed ID: 14610009
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
18. [Peroxisome proliferator activated receptors and cardiovascular disorders].
Norata GD; Pellegatta F; Catapano AL
Ital Heart J Suppl; 2003 Jan; 4(1):8-18. PubMed ID: 12690929
[TBL] [Abstract][Full Text] [Related]
19. PPARs in the brain.
Heneka MT; Landreth GE
Biochim Biophys Acta; 2007 Aug; 1771(8):1031-45. PubMed ID: 17569578
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
